XML 113 R77.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
entity
Dec. 31, 2023
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | entity 1  
Segment Reporting Information [Line Items]    
Research and development $ 33,656 $ 23,849
Employee related general and administrative expenses 11,330 11,896
Net loss (51,898) (35,195)
Total segment assets 28,178 27,146
Reportable Segment    
Segment Reporting Information [Line Items]    
Contract and grant reimbursements (1,027) (3,800)
Employee related general and administrative expenses 3,682 3,437
Professional fees and other general and administrative expenses 7,648 8,455
Other segment items 6,912 (445)
Net loss 51,898 35,195
Total segment assets 28,178 27,146
Clinical trial expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 15,892 7,066
Employee related research and development expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 8,560 7,306
Chemistry, manufacturing and controls expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 4,260 7,623
Other research and development expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development $ 5,971 $ 5,553